News Daily News Semaglutide Cuts Risk of Major Cardiovascular Events in Type 2 Diabetes: SUSTAIN-6 Michael O'Riordan September 16, 2016
News Industry News New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions With Cardiovascular Outcomes And Mortality November 17, 2015
News Daily News Studies Support DES Use in Diabetics, But Results Vary by Device Caitlin E. Cox March 08, 2011